Plasmodium falciparum hemoglobin digestion pathway

The Plasmodium falciparum hemoglobin digestion pathway is a critical metabolic process occurring within the parasite's acidic food vacuole during the intraerythrocytic stage of its life cycle. The parasite ingests host cell hemoglobin and degrades it using a suite of proteases, including aspartic proteases (plasmepsins), cysteine proteases (falcipains), and metalloproteases (falcilysin), to obtain essential amino acids for protein synthesis. A byproduct of this digestion is free heme (ferriprotoporphyrin IX), which is highly toxic to the parasite as it generates reactive oxygen species and damages membranes. To survive, the parasite detoxifies heme by sequestering it into an insoluble, inert crystalline form called hemozoin (malaria pigment), a process facilitated by the Heme Detoxification Protein (HDP). This pathway is the primary target for several major classes of antimalarial drugs, most notably the 4-aminoquinolines (e.g., chloroquine) and amino alcohols (e.g., quinine), which interfere with hemozoin formation, leading to the accumulation of toxic heme and parasite death. While the exact molecular targets of some drugs in this pathway were historically described as "unknown," research has identified specific enzymes and transporters, such as PfCRT (Chloroquine Resistance Transporter), that play pivotal roles in drug action and resistance. Disruption of this pathway remains a cornerstone of malaria chemotherapy, although the emergence of resistant strains poses a significant challenge to global health efforts.

Other names

Hemoglobin uptake and digestion pathwayHeme detoxification pathwayFood vacuole digestion processHemozoin formation pathway

Inhibition of the conversion of toxic free heme into inert hemozoin crystals, and/or inhibition of the proteolytic enzymes (plasmepsins, falcipains) responsible for degrading host hemoglobin into amino acids.